Aligos Therapeutics Inc
F:5WK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
Duerr AG
F:DUE
|
DE |
|
D
|
DigitalOcean Holdings Inc
DUS:0SU
|
US |
|
Swatch Group AG
SIX:UHR
|
CH |
|
M
|
Mitsubishi Estate Co Ltd
XBER:MES
|
JP |
|
Strongpoint ASA
F:PGT
|
NO |
|
R
|
Ralph Lauren Corp
XMUN:PRL
|
US |
|
Insulet Corp
NASDAQ:PODD
|
US |
|
R
|
Ryanair Holdings PLC
SWB:RY4C
|
IE |
|
Five Below Inc
LSE:0IPD
|
US |
|
I
|
Insulet Corp
XMUN:GOV
|
US |
|
Pro Medicus Ltd
OTC:PMDIY
|
AU |
|
Q
|
Quest Diagnostics Inc
LSE:0KSX
|
US |
|
C
|
Central Japan Railway Co
SWB:JAP
|
JP |
|
L
|
Lowe's Companies Inc
XMUN:LWE
|
US |
Bankruptcy Probability
Aligos Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aligos Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
34.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aligos Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aligos Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.